- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 16/14 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux contre du matériel provenant de champignons, d'algues ou de lichens
Détention brevets de la classe C07K 16/14
Brevets de cette classe: 346
Historique des publications depuis 10 ans
|
24
|
36
|
19
|
17
|
34
|
36
|
15
|
25
|
19
|
8
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The University Court of the University of Aberdeen | 117 |
10 |
| Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center | 114 |
9 |
| Board of Supervisors of Louisiana State University and Agricultural and Mechanical College | 825 |
8 |
| Biotalys N.V. | 51 |
8 |
| UCB Biopharma SPRL | 332 |
7 |
| University of Georgia Research Foundation, Inc. | 1078 |
7 |
| The Johns Hopkins University | 5913 |
6 |
| Biotest AG | 100 |
6 |
| Dynamiker Biotechnology (Tianjin) Co.,Ltd | 21 |
6 |
| Hibercell, Inc. | 70 |
6 |
| Agrosavfe N.V. | 9 |
5 |
| The Governors of the University of Alberta | 874 |
5 |
| Katholieke Universiteit Leuven | 1298 |
5 |
| Atara Biotherapeutics, Inc. | 63 |
4 |
| Hiroshima University | 588 |
4 |
| Wellstat Vaccines, LLC | 6 |
4 |
| The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | 52 |
4 |
| UCB Biopharma SRL | 599 |
4 |
| CZ Biohub Sf, LLC | 160 |
4 |
| F. Hoffmann-La Roche AG | 7808 |
3 |
| Autres propriétaires | 231 |